<DOC>
	<DOCNO>NCT00700765</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study evaluate incidence adverse event use Levemir速 normal clinical practice condition .</brief_summary>
	<brief_title>Observational Study Evaluate Safety Levemir速 Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 1 type 2 diabetes mellitus Subjects unlikely comply protocol Subjects currently treat Levemir速 Subjects previously enrol study Subjects hypersensitivity Levemir速 excipients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>